Rhythm Biosciences Limited (ASX:RHY)

Rhythm Biosciences Revenue

Rhythm Biosciences had revenue of 3.17M AUD in the half year ending December 31, 2024, with 16.37% growth. This brings the company's revenue in the last twelve months to 3.17M, up 53.33% year-over-year. In the fiscal year ending June 30, 2024, Rhythm Biosciences had annual revenue of 1.69M, down -45.41%.

• Revenue (ttm): 3.17M
• Revenue Growth: +53.33%
• P/S Ratio: 4.84
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 15.34M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	1.69M	-1.41M	-45.41%
Jun 30, 2023	3.10M	668.44K	27.54%
Jun 30, 2022	2.43M	1.32M	118.98%
Jun 30, 2021	1.11M	1.01M	1,008.51%
Jun 30, 2020	100.00K	-927.62K	-90.27%